Spectrawave’s tools are intended to improve PCI treatment and will be integrated into Philips’ Azurion imaging platform.
In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...
HANGZHOU, China, Dec. 16, 2025 /PRNewswire/ -- Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio ...
Willis Knighton Health (North) has been designated a Chest Pain Center with Primary PCI Accreditation for the19 th year by the American College of Cardiology. The PCI designation means Willis Knighton ...
Coronary artery bypass grafting yields better 5-year outcomes in women with chronic severe coronary artery disease than percutaneous coronary intervention, a study finds.
Survival, quality of life, and efficacy remained similar in the 3 years after TAVI for patients with versus without blockages ...
Landmark procedure strengthens Africa's capacity for complex cardiac care, reducing reliance on overseas medical travelAbuja, Nigeria,15th December, 2025 -- Only six months since its opening in June ...
Vesalio, a leader in thrombectomy solutions, today announced FDA 510(k) clearance and the upcoming U.S. commercial launch of ...
A recent systematic review and meta-analysis concluded that there is no significant difference in most safety outcomes ...